Indications |
Intravenous Postoperative respiratory depression Adult: Initially, 0.5-1.5 mg/kg given via IV inj over at least 30 sec. May repeat hrly, if necessary. Alternatively, it can be given via IV infusion at an initial rate of 2-5 mg/minute, may reduce to 1-3 mg/minute according to patient's response. Max total: 4 mg/kg. Intravenous Acute respiratory failure Adult: 1.5-4 mg/minute by IV infusion. |
Contraindications |
Severe heart disease and hypertension; epilepsy, cerebral oedema, hyperthyroidism, ischaemic heart disease, acute severe asthma, convulsive disorders, phaeochromocytoma, cerebrovascular accident, head injury, physical obstruction of the airway. |
Warnings / Precautions |
Heart diseases, hepatic or renal impairment. Monitor BP, pulse rate and deep tendon reflexes. Rapid infusion may result in haemolysis. Protect and maintain adequate airway. |
Adverse Reactions |
Dyspnoea and other respiratory problems. Muscle involvement may range from fasciculations to spasticity or seizures. Headache, dizziness, confusion, hyperactivity, hyperpyrexia particularly in the genital or perineal regions. Nausea, vomiting, diarrhoea, problems with urination. Alterations of BP and various arrhythmias. Thrombophloebitis following extravasation. |
Overdose Reactions |
Symptoms include hypertension, tachycardia, skeletal muscle hyperactivity, enhanced deep tendon reflexes, agitation, confusion, sweating, cough and dyspnoea. Monitor BP, pulse rate and deep tendon reflexes periodically. Management should be symptomatic. |
Drug Interactions |
Pressor effects enhanced by sympathomimetics or MAOIs. Masks residual effects of muscle relaxants. Cardiac arrhythmias with anaesthetics known to sensitise the myocardium. Concurrent use with aminophylline may manifest agitation and increased skeletal muscle activity. See Below for More doxapram Drug Interactions |
Mechanism of Actions |
Doxapram is a central and respiratory stimulant which acts by stimulating the peripheral chemoreceptors and central respiratory centers. At higher doses, stimulation of the other parts of the brain and spinal cord occurs. Doxapram also has pressor action and may increase catecholamine release. It improves respiratory depression induced by opioids without affecting analgesia. Distribution: Rapidly distributed into the tissues after IV admin. Metabolism: Extensive first-pass effect after IV inj. Excretion: Metabolites and a small amount of unchanged drug are excreted via bile to the faeces. |
Storage Conditions |
Intravenous: Store at 15-30°C. |
ATC Classification |
R07AB01 - doxapram ; Belongs to the class of respiratory stimulants. Used in treatment of respiratory diseases. |
Storage |
Intravenous: Store at 15-30°C. |
Available As |
|
Doxapram
Post Review about Doxapram Click here to cancel reply.
Doxapram Containing Brands
Doxapram is used in following diseases
Drug - Drug Interactions of Doxapram
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.